Breast Tumor Board: A 10-Years Retrospective Review of the Multidisciplinary Team Approach to Breast Cancer Patients in the Largest Academic Cancer Center in Iran

نویسندگان

1 Breast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran

2 Department of Surgery, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran

3 Breast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran

4 Department of Surgical Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran

5 Breast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran

doi
10.22034/ircmj.2024.198898
چکیده

Background and Objectives: Breast cancer management requires a team effort to enhance patient care and improve outcomes. In developed countries, multidisciplinary team (MDT) meetings have become essential parts of cancer management. However, this concept is still new in these countries. Our study aimed to review the activities of the recent 10 years of Breast MDT (BMDT) to evaluate its impact on the management of complex cases of breast cancer   Methods: In 2008, BMDT was separated from the general tumor board of the Cancer Institute of Tehran University of Medical Sciences, and has since continued as a structured weekly meeting. In this study, we present a review of its activities and outcomes in the two consecutive recent 5-year periods.   Results: We have collected data from 1215 cases that were introduced in weekly sessions over the last 10 years. The department of surgery referred 74.4% of patients. The most common question was about the necessity of adjuvant chemotherapy versus endocrine therapy alone. We observed that the number of cases introduced in the second 5-year period was 1.8 times higher than in the first 5 years. A review of imaging documents in 116 patients showed that in 62 cases (53.4%), the results of the reported images were corrected upon re-evaluation by expert radiologists, and in 25 out of 62 patients (40%), the treatment plans were changed.   Conclusion: There has been a rising trend in the presentation of challenging breast cancer cases in the BMDT meeting during recent years, influencing treatment decisions.